Zobrazeno 1 - 7
of 7
pro vyhledávání: '"CUTRER, F.M"'
Autor:
Diener, H.C., Dodick, D.W., Aurora, S.K., Turkel, C.C., DeGryse, R.E., Lipton, R.B., Silberstein, S.D., Brin, M.F., PREEMPT 2 Chronic Migraine Study Group, Becker, W.J., Blumenfeld, A., Cutrer, F.M., Gendolla, A., Lay, C., Martin, V., Relja, Maja, Schim, J.D., Smith, T.R., Ward, T.W., Winner, P.
Objectives: This is the second of a pair of studies designed to evaluate the efficacy and safety of onabotulinumtoxinA (BOTOX®) for prophylaxis of headaches in adults with chronic migraine. Methods: PREEMPT 2 was a phase 3 study, with a 24-week, dou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::738ff165cdbb583bbfd9e34a56aaccc7
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=77953223552
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=77953223552
Autor:
Aurora, S.K., Dodick, D.W., Turkel, C.C., DeGryse, R.E., Silberstein, S.D., Lipton, R.B., Diener, H.C., Brin, M.F., PREEMPT 1 Chronic Migraine Study Group, Becker, W.J., Blumenfeld, A., Cutrer, F.M., Gendolla, A., Lay, C., Martin, V., Relja, Maja, Schim, J.D., Smith, T.R., Ward, T.W., Winner, P.
Objectives: This is the first of a pair of studies designed to assess efficacy, safety and tolerability of onabotulinumtoxinA (BOTOX®) as headache prophylaxis in adults with chronic migraine. Methods: The Phase III REsearch Evaluating Migraine Proph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6492251aec7f4184f71c751ff52ac780
https://www.ncbi.nlm.nih.gov/pubmed/20647170
https://www.ncbi.nlm.nih.gov/pubmed/20647170
Publikováno v:
Neuropharmacology; January 1997, Vol. 36 Issue: 1 p83-91, 9p
Publikováno v:
Neuroscience; February 1995, Vol. 64 Issue: 3 p741-750, 10p
Publikováno v:
Neuropharmacology; 1999, Vol. 38 Issue: 7 p1043-1053, 11p
Autor:
Cutrer, F.M., Baloh, R.W.
Publikováno v:
Journal of the Canadian Chiropractic Association. Mar1993, Vol. 37 Issue 1, p59. 1p.
Publikováno v:
In Neuropharmacology January 1997 36(1):83-91